BHARAT PARENTERALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,510 INR | -0.18% |
|
+6.26% | +86.40% |
| Sales 2023 | 2.19B 26.25M 35.96M | Sales 2024 | 2.59B 31.05M 42.53M | Capitalization | 6.53B 78.17M 107M |
|---|---|---|---|---|---|
| Net income 2023 | 243M 2.91M 3.98M | Net income 2024 | 145M 1.74M 2.38M | EV / Sales 2023 | 1.08 x |
| Net Debt 2023 | 419M 5.01M 6.87M | Net Debt 2024 | 1.47B 17.56M 24.05M | EV / Sales 2024 | 3.08 x |
| P/E ratio 2023 |
7.97
x | P/E ratio 2024 |
45
x | Employees | 363 |
| Yield 2023 |
0.22% | Yield 2024 |
0.09% | Free-Float | 34.65% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.18% | ||
| 1 week | +6.26% | ||
| Current month | +11.06% | ||
| 1 month | +3.61% | ||
| 3 months | +31.28% | ||
| 6 months | +98.68% | ||
| Current year | +86.40% |
1 week
1 350.60
1 566.00
1 month
1 300.001 566.00
Current year
743.001 824.70
1 year
365.001 824.70
3 years
297.901 824.70
5 years
131.001 824.70
10 years
116.251 824.70
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 92-09-02 | |
| Director of Finance/CFO | - | 18-08-13 | |
| Compliance Officer | - | 23-10-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 92-09-02 | |
| Director/Board Member | 55 | 10-07-07 | |
| Director/Board Member | 60 | 17-08-02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-26 | 1,510 | -0.18% | 2 668 |
| 24-06-25 | 1,513 | +4.76% | 7,373 |
| 24-06-24 | 1,444 | +4.03% | 1,649 |
| 24-06-21 | 1,388 | +1.36% | 374 |
| 24-06-20 | 1,369 | -2.23% | 249 |
Delayed Quote Bombay S.E., June 26, 2024 at 06:00 am
More quotes
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies.
Sector
Pharmaceuticals
Calendar
2024-07-02
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +86.40% | 118M | |
| +54.71% | 815B | |
| +44.25% | 654B | |
| -6.51% | 354B | |
| +22.06% | 337B | |
| +10.45% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +9.28% | 171B |
- Stock Market
- Equities
- BPLPHARMA6 Stock
